GRANULES PHARMS FDA Approval ANDA 213185

ANDA 213185

GRANULES PHARMS

FDA Drug Application

Application #213185

Application Sponsors

ANDA 213185GRANULES PHARMS

Marketing Status

Prescription001

Application Products

001CAPSULE, EXTENDED RELEASE;ORAL60MG0TROSPIUM CHLORIDETROSPIUM CHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2020-04-23STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

GRANULES PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213185
            [companyName] => GRANULES PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"TROSPIUM CHLORIDE","activeIngredients":"TROSPIUM CHLORIDE","strength":"60MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/23\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-04-23
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.